Pfizer revenue rises 11% | Fin24
  • Covid-19 Money Hub

    The hub will help answer your business and money questions during the coronavirus crisis.

  • Cigarettes

    The tobacco ban is a 'deal with the devil' that undermines transformation, say lobby groups.

  • Easing the Lockdown

    Liquor makers want bars to become drink-collection points when the alcohol ban lifts.


Pfizer revenue rises 11%

Aug 02 2016 13:05

London - Pfizer's quarterly revenue rose about 11%, driven by sales of newer drugs and the acquisition of hospital products company Hospira last year.

The largest US drugmaker's revenue rose to $13.15bn in the second quarter from $11.85bn, a year earlier.

The company's net income fell to $2.02bn, or 33 cents per share, from $2.63bn, or 42 cents per share.

Pfizer in April terminated its $160bn tax inversion deal to acquire Irish drugmaker Allergan.

Read Fin24's top stories trending on Twitter:

pfizer  |  health  |  earnings reports


Company Snapshot

Voting Booth

How has Covid-19 impacted your financial position?

Previous results · Suggest a vote